Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial (Q42672645)
Jump to navigation
Jump to search
scientific article published on 11 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial |
scientific article published on 11 October 2012 |
Statements
1 reference
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial (English)
1 reference
O Vaccaro
1 reference
M Masulli
1 reference
E Bonora
1 reference
S Del Prato
1 reference
C B Giorda
1 reference
A P Maggioni
1 reference
P Mocarelli
1 reference
A Nicolucci
1 reference
A A Rivellese
1 reference
S Squatrito
1 reference
G Riccardi
1 reference
TOSCA.IT study group (Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents. Intervention Trial)
1 reference
11 October 2012
1 reference
1 reference
Identifiers
1 reference